iguratimod has been researched along with bradykinin in 2 studies
| Studies (iguratimod) | Trials (iguratimod) | Recent Studies (post-2010) (iguratimod) | Studies (bradykinin) | Trials (bradykinin) | Recent Studies (post-2010) (bradykinin) |
|---|---|---|---|---|---|
| 134 | 19 | 109 | 14,195 | 355 | 1,520 |
| Protein | Taxonomy | iguratimod (IC50) | bradykinin (IC50) |
|---|---|---|---|
| B2 bradykinin receptor | Homo sapiens (human) | 0.0018 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asaoka, K; Eguchi, M; Kitamura, R; Makino, S; Shimotori, T; Tanaka, K; Yoshida, C | 1 |
| Aikawa, Y; Inaba, T; Kawasaki, H; Kurata, K; Tanaka, K; Tsukamoto, Y | 1 |
2 other study(ies) available for iguratimod and bradykinin
| Article | Year |
|---|---|
Pharmacological studies on 3-formylamino-7-methylsulfonylamino-6-phenoxy-4H-1-benzopyran-4-one (T-614), a novel antiinflammatory agent. 3rd communication: the involvement of bradykinin in its analgesic actions.
Topics: Analgesia; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzopyrans; Bradykinin; Kaolin; Male; Mice; Mice, Inbred ICR; Prekallikrein; Rats; Rats, Wistar; Serine Endopeptidases; Sulfonamides; Zymosan | 1992 |
T-614, a novel antirheumatic drug, inhibits both the activity and induction of cyclooxygenase-2 (COX-2) in cultured fibroblasts.
Topics: 3T3 Cells; Actins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Base Sequence; Benzopyrans; Blotting, Northern; Bradykinin; Cells, Cultured; Cyclooxygenase Inhibitors; Dinoprostone; DNA Primers; Enzyme Activation; Enzyme Induction; Fibroblasts; Gene Expression Regulation, Enzymologic; In Vitro Techniques; Mice; Molecular Sequence Data; Polymerase Chain Reaction; Prostaglandin-Endoperoxide Synthases; Sulfonamides | 1995 |